US Edition
Published • loading... • Updated
Catheter Precision Divests Non-Core Assets As It Shifts Focus - Catheter Precision (AMEX:VTAK)
Summary by Benzinga
1 Articles
1 Articles
Catheter Precision Divests Non-Core Assets As It Shifts Focus - Catheter Precision (AMEX:VTAK)
Catheter Precision (NYSE:VTAK) shares are down on Thursday as the company announced a strategic divestiture of its non-core assets. VTAK Sells Atherectomy Catheter Tech to Focus on Electrophysiology Catheter Precision on Thursday agreed to sell its atherectomy catheter technologies, including associated FDA approvals and patents, to a strategic acquirer. This decision aims to enhance capital efficiency and sharpen the company’s focus on its high…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
